Sam Brusco, Associate Editor04.06.22
Upper and lower extremity firm Extremity Medical today filed a lawsuit in the U.S. District Court of Delaware against Nextremity Solutions and Zimmer Biomet alleging the companies infringed on a patent for its intraosseous fixation platform when marketing the InCore lapidus system.
Extremity Medical has an intellectual property portfolio of 49 U.S. patents and several foreign countries. The firm’s intraosseous fixation platform is a zero-profile upper and lower extremity bone fusion and fixation solution that can be implanted via minimal incisions.
Extremity markets the technology under trade names IO FiX, IO FiX Plus, IO FiX 2.0, IO Freedom, CarpalFiX, ApeX, and XMCP.’’ “Extremity Medical has invested a tremendous amount of effort and resources in research and development to create innovative technology to improve the lives of patients and meet surgeons’ needs. Our intellectual property is a critical component in making such advancements possible and we are committed to protecting it,” Extremity Medical founder, chairman, and CEO Matthew Lyons told the press.
Extremity Medical has an intellectual property portfolio of 49 U.S. patents and several foreign countries. The firm’s intraosseous fixation platform is a zero-profile upper and lower extremity bone fusion and fixation solution that can be implanted via minimal incisions.
Extremity markets the technology under trade names IO FiX, IO FiX Plus, IO FiX 2.0, IO Freedom, CarpalFiX, ApeX, and XMCP.’’ “Extremity Medical has invested a tremendous amount of effort and resources in research and development to create innovative technology to improve the lives of patients and meet surgeons’ needs. Our intellectual property is a critical component in making such advancements possible and we are committed to protecting it,” Extremity Medical founder, chairman, and CEO Matthew Lyons told the press.